Article Details

Zacks: Analysts Set $5.00 Price Target for Bellerophon Therapeutics Inc (BLPH)

Retrieved on: 2018-08-09 04:31:35

Tags for this article:

Click the tags to see associated articles and topics

Zacks: Analysts Set $5.00 Price Target for Bellerophon Therapeutics Inc (BLPH). View article details on hiswai:

Excerpt

<div><b>Renaissance Technologies</b> LLC now owns 927,200 shares of the biotechnology company's stock valued at $2,392,000 after acquiring an additional ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up